Tilray Expands Premium Cannabis Offerings Amid Strategic Beverage Push

Tilray reports record Q2 revenue, narrows loss, and announces dual strategy: new high-THC cannabis line and major US beverage deal with Carlsberg Group.

Tilray Brands is deepening its presence in Canada's premium cannabis market with a new high-potency product launch from its subsidiary Good Supply. This move comes as the company's shares face continued pressure and it executes a strategic pivot in its beverage division through a major partnership.

Quarterly Performance Shows Mixed Results

For the second quarter of its 2026 fiscal year, Tilray reported record net revenue of $217.5 million, exceeding analyst forecasts of $210.4 million. The company's net loss narrowed significantly to $43.5 million, compared to $85.3 million in the prior-year period. On a per-share basis, the loss improved to negative $0.41 from negative $0.99 a year earlier.

Operating cash flow also showed improvement, coming in at negative $8.5 million versus negative $40.7 million for the same quarter last year. A breakdown of segment performance revealed a 3% increase in cannabis revenue to $67.5 million, while beverage segment revenue declined by 20% to $50.1 million. The company ended the quarter with $246.7 million in cash and equivalents.

Tilray reaffirmed its full-year 2026 adjusted EBITDA guidance of $62–72 million. Its next quarterly report is scheduled for April 7, 2026.

New Cannabis Line Targets High-Potency Demand

On February 26, 2026, Tilray announced the spring collection launch for its Good Supply brand. The seasonal lineup is focused on high-growth formats, including potent vapes, flower, and expanded pre-roll offerings.

The product line features two 1g 510-thread vape cartridges with THC concentrations ranging from 91% to 97%. It also includes new flower packages in 28g and 7g formats, alongside limited drops with THC levels between 24% and 32%. Availability will vary across Canadian provinces.

"Good Supply sits at the intersection of innovation, potency, and accessibility," stated Blair MacNeil, President of Tilray Brands Canada. He emphasized that the launch is a direct response to robust consumer demand for flavorful, high-quality cannabis products.

Strategic Beverage Partnership with Carlsberg

Just prior to the cannabis announcement, on February 18, 2026, Tilray entered into a multi-year licensing agreement with the Carlsberg Group. Beginning in January 2027, Tilray will gain the rights to produce, market, and distribute Carlsberg®, Carlsberg Elephant®, 1664®, and Kronenbourg 1664 Blanc® brands in the United States.

The initial term of the agreement is five years, with an automatic renewal for another five years provided certain performance metrics are met. Carlsberg acknowledged that the U.S. market currently contributes less than 0.1% of its global revenue. The partnership allows for local production through Tilray's existing brewery infrastructure, creating a platform for growth.

As one of the largest craft beer producers in the U.S., ranking fourth according to the Brewers Association in 2025, Tilray positions this deal as a lever for its premium and import beer business, despite broader industry headwinds from declining beer consumption.

Share Price and Market Challenges Persist

Tilray's stock declined by 1.1% on February 27, closing at $7.83. Trading volume of 1.7 million shares was notably weak, sitting 60% below the three-month average of 4.3 million shares.

Technical indicators point to ongoing weakness, with the share price trading below both its 50-day and 200-day moving averages. The stock's 52-week range of $3.51 to $23.20 underscores the high volatility characteristic of the cannabis sector.

Analyst sentiment reflects caution. Roth MKM reduced its price target on Tilray shares from $20 to $10 on January 20, maintaining a neutral rating.

Multi-Segment Strategy Faces Headwinds

Tilray operates a diversified platform with over 40 brands across more than 20 countries, spanning cannabis, hemp-based foods, and craft beverages. The company's dual strategy involves expanding high-potency cannabis products in Canada while scaling its U.S. beverage business through the Carlsberg partnership, aiming to reposition itself as a diversified consumer goods company.

The company continues to navigate several challenges, including regulatory uncertainty, cannabis market saturation, macroeconomic pressures, and softness in the craft beer segment. Following the Carlsberg announcement, shares saw a modest gain of 0.93%. The upcoming April earnings report will provide further insight into whether the beverage segment can effectively offset margin pressures in cannabis.

Key Financial Metrics at a Glance

Metric	Value
Q2 2026 Net Revenue	$217.5 million (Record)
Q2 2026 Net Loss	$43.5 million (Prior Year: $85.3 million)
Cash & Equivalents (Q2)	$246.7 million
2026 Adj. EBITDA Guidance	$62–72 million
Next Quarterly Report	April 7, 2026
52-Week Trading Range	$3.51 – $23.20